Publicacións nas que colabora con Ángel Luís Fernández González (32)

2024

  1. Carbohydrate antigen 125 on epicardial fat and its association with local inflammation and fibrosis-related markers

    Journal of Translational Medicine, Vol. 22, Núm. 1

  2. Edoxaban treatment in a post-infarction experimental model

    European Journal of Pharmacology, Vol. 962

  3. Enhanced Levels of Adiposity, Stretch and Fibrosis Markers in Patients with Coexistent Heart Failure and Atrial Fibrillation

    Journal of Cardiovascular Translational Research, Vol. 17, Núm. 1, pp. 13-23

  4. Videolaryngoscope versus conventional technique for insertion of a transesophageal echocardiography probe in intubated ICU patients (VIDLARECO trial): A randomized clinical trial

    Anaesthesia Critical Care and Pain Medicine, Vol. 43, Núm. 2

2023

  1. Clinical Profiling and Biomarkers for Post-Operative Atrial Fibrillation Prediction in Patients Undergoing Cardiac Surgery

    Journal of Clinical Medicine, Vol. 12, Núm. 10

2022

  1. Synergism between obesity and HFpEF on neutrophils phenotype and its regulation by adipose tissue-molecules and SGLT2i dapagliflozin

    Journal of Cellular and Molecular Medicine, Vol. 26, Núm. 16, pp. 4416-4427

  2. The Effect of Mineralocorticoid Receptor 3 Antagonists on Anti-Inflammatory and Anti-Fatty Acid Transport Profile in Patients with Heart Failure

    Cells, Vol. 11, Núm. 8

2020

  1. CD5L, Macrophage Apoptosis Inhibitor, Was Identified in Epicardial Fat-Secretome and Regulated by Isoproterenol From Patients With Heart Failure

    Frontiers in Physiology, Vol. 11

  2. Inflammatory and lipid regulation by cholinergic activity in epicardial stromal cells from patients who underwent open-heart surgery

    Journal of Cellular and Molecular Medicine, Vol. 24, Núm. 18, pp. 10958-10969

2019

  1. Cholinergic activity regulates the secretome of epicardial adipose tissue: Association with atrial fibrillation

    Journal of Cellular Physiology, Vol. 234, Núm. 7, pp. 10512-10522

  2. Combined Venoarterial Extracorporeal Membrane Oxygenation and Impella for Diffuse Coronary Spasm After Surgical Myocardial Revascularization

    Revista Espanola de Cardiologia, Vol. 72, Núm. 3, pp. 258-259

  3. Plasma FABP4 levels are associated with left atrial fat volume in persistent atrial fibrillation and predict recurrence after catheter ablation

    International Journal of Cardiology, Vol. 292, pp. 131-135

2018

  1. Effects of dapagliflozin on human epicardial adipose tissue: Modulation of insulin resistance, inflammatory chemokine production, and differentiation ability

    Cardiovascular Research, Vol. 114, Núm. 2, pp. 336-346

  2. Mixoma del tracto de salida del ventrículo derecho

    Cirugia Cardiovascular, Vol. 25, Núm. 1, pp. 41-44

  3. Nutrients restriction upregulates adiponectin in epicardial or subcutaneous adipose tissue: Impact in de novo heart failure patients

    International Journal of Medical Sciences, Vol. 15, Núm. 5, pp. 417-424

2017

  1. Late Detachment of an Aortic Prosthetic Valve and Reactivation of Takayasu Arteritis

    Revista Espanola de Cardiologia, Vol. 70, Núm. 5, pp. 397-399

  2. Omentin treatment of epicardial fat improves its anti-inflammatory activity and paracrine benefit on smooth muscle cells

    Obesity, Vol. 25, Núm. 6, pp. 1042-1049

2016

  1. Glucose and Inflammatory Cells Decrease Adiponectin in Epicardial Adipose Tissue Cells: Paracrine Consequences on Vascular Endothelium

    Journal of Cellular Physiology, Vol. 231, Núm. 5, pp. 1015-1023

  2. Sea cucumbers with an anti-inflammatory effect on endothelial cells and subcutaneous but not on epicardial adipose tissue

    Food and Function, Vol. 7, Núm. 2, pp. 953-963

2015

  1. Orosomucoid secretion levels by epicardial adipose tissue as possible indicator of endothelial dysfunction in diabetes mellitus or inflammation in coronary artery disease

    Atherosclerosis, Vol. 235, Núm. 2, pp. 281-288